Pages that link to "Q59064514"
Jump to navigation
Jump to search
The following pages link to A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma (Q59064514):
Displaying 50 items.
- Fasting: the history, pathophysiology and complications (Q24536099) (← links)
- Nicotine from cigarette smoking enhances clonidine-induced increase of serum growth hormone concentrations in men (Q24544072) (← links)
- Relationship between serum sex hormones and glucose, insulin and lipid abnormalities in men with myocardial infarction (Q24561737) (← links)
- Diminished brain glucose metabolism is a significant determinant for falling rates of systemic glucose utilization during sleep in normal humans (Q24609701) (← links)
- Growth hormone secretion during sleep (Q24615018) (← links)
- Bromocriptine treatment in Parkinson's disease (Q28328929) (← links)
- Actions of calcium ions and a calcium-influx blocker on basal and TRH- and GnRH-stimulated hormone release in patients with pituitary adenomas (Q30462317) (← links)
- Different control of GH secretion by gamma-amino- and gamma-hydroxy-butyric acid in 4-year abstinent alcoholics (Q31870699) (← links)
- Carbohydrate metabolism in dystrophia myotonica (Q33586475) (← links)
- Chromosome banding studies in two patients with XXXXY syndrome (Q33588214) (← links)
- Bromocriptine in Parkinsonism: long-term treatment, dose response, and comparison with levodopa (Q33756251) (← links)
- Neuroendocrine responses to glucose ingestion in man. Specificity, temporal relationships, and quantitative aspects (Q33821879) (← links)
- Recombinant growth hormone enhances muscle myosin heavy-chain mRNA accumulation and amino acid accrual in humans (Q33854658) (← links)
- Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia (Q33892550) (← links)
- Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test. (Q33922072) (← links)
- Abnormalities in carbohydrate tolerance associated with elevated plasma nonesterified fatty acids (Q33961685) (← links)
- Effect of adrenergic-blocking or -stimulating agents on plasma growth hormone, immunoreactive insulin, and blood free fatty acid levels in man (Q34060871) (← links)
- Effect of lipids on growth hormone secretion in humans (Q34062745) (← links)
- Plasma insulin disturbances in primary hyperparathyroidism (Q34067715) (← links)
- Human prolactin and thyrotropin concentrations in the serums of normal and hypopituitary children before and after the administration of synthetic thyrotropin-releasing hormone (Q34073392) (← links)
- RADIOIMMUNOASSAY OF HUMAN PLASMA THYROTROPIN. (Q34079411) (← links)
- Suppression of growth hormone (GH) secretion by a selective GH-releasing hormone (GHRH) antagonist. Direct evidence for involvement of endogenous GHRH in the generation of GH pulses (Q34170486) (← links)
- Epinephrine is not critical to prevention of hypoglycemia during exercise in humans (Q34182136) (← links)
- Permanent neonatal diabetes mellitus: A case report with plasma insulin studies (Q34217942) (← links)
- Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers (Q34270733) (← links)
- Measurement of human luteinizing hormone in plasma by radioimmunoassay (Q34273114) (← links)
- Adrenergic receptor control mechanism for growth hormone secretion (Q34276628) (← links)
- Pituitary-testicular responsiveness in male hypogonadotropic hypogonadism (Q34461231) (← links)
- Nyctohemeral growth hormone levels in children with growth retardation and inflammatory bowel disease , (Q34475916) (← links)
- Suppression of sleep-related prolactin secretion and enhancement of sleep-related growth hormone secretion (Q34481814) (← links)
- Neural control of counter-regulatory events during glucopenia in man. (Q34508674) (← links)
- Stimulation of Human Prolactin Secretion by Intravenous Infusion of L-Tryptophan (Q34509530) (← links)
- Bromocriptine and dopamine receptor stimulation (Q34515404) (← links)
- Amphetamines, growth hormone and narcolepsy (Q34515812) (← links)
- Plasma bromocriptine levels, clinical and growth hormone responses in Parkinsonism (Q34516976) (← links)
- Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion (Q34519321) (← links)
- Direct muscarinic cholinergic inhibition of hepatic glucose production in humans (Q34559150) (← links)
- Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms (Q34563673) (← links)
- Enhancement of insulin action after oral glucose ingestion (Q34573587) (← links)
- Epinephrine supports the postabsorptive plasma glucose concentration and prevents hypoglycemia when glucagon secretion is deficient in man (Q34602608) (← links)
- Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epine (Q34629732) (← links)
- Impaired growth in hyperkinetic children receiving pemoline (Q34698048) (← links)
- Studies of substrate regulation in fasting. II. Effect of infusion of glucose io the carotid artery upon fasting lipolysis in the baboon (Q35571921) (← links)
- Adaptation in brain glucose uptake following recurrent hypoglycemia (Q35782351) (← links)
- Psychosocial short stature: a syndrome with many variables (Q35831832) (← links)
- Growth Hormone: Metabolic Clearance Rates, Integrated Concentrations, and Production Rates in Normal Adults and the Effect of Prednisone (Q35898842) (← links)
- The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man (Q35902201) (← links)
- Growth hormone investigation in patients with mental dysfunction (Q35909696) (← links)
- Growth hormone, prolactin and thyrotrophin responses to thyrotrophin-releasing hormone in diabetic patients (Q36716141) (← links)
- Growth hormone assays: current methodologies and their limitations (Q36789081) (← links)